Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s10020-020-00184-0 http://scihub22266oqcxt.onion/10.1186/s10020-020-00184-0 32600316!7322708!32600316     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Mol+Med 2020 ; 26 (1): 64 Nephropedia Template TP {{tp|p=32600316|t=2020. The cholinergic anti-inflammatory pathway alleviates acute lung injury |pdf=|usr=}}{{32600316}} gab.com Text The cholinergic anti-inflammatory pathway alleviates acute lung injury JO: Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=32600316 #FOAvip The ubiquiotous nuclear protein HMGB1 is extracellularly released by dying cells or activated innate immunity cells to promote inflammation. Extracellular HMGB1 plays a prominent role in the pathogenesis of acute lung injury of infectious as well as sterile origin including hyperoxia. Excessive amounts of systemic HMGB1 and HMGB1-partner molecule complexes can be retained in the pulmonary circulation indicated by a substantial reduction of HMGB1 plasma levels in arterial versus venous blood. The cholinergic antiinflammatory mechanism ameliorates pulmonary inflammation by inhibiting HMGB1 release and HMGB1 receptor expression. This comprehension was recently reinforced by results reported in Molecular Medicine by Sitapara and coworkers demonstrating that administration of an alpha7 nicotinic acetylcholine receptor agonist attenuated hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation. Activating the cholinergic antiinflammatory path might be considered to alleviate severe COVID-19 with or without concurrent oxygen-induced lung injury. Twit Text FOAVip The cholinergic anti-inflammatory pathway alleviates acute lung injury ????Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=32600316 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32600316 #FOAvip English Wikipedia <ref>{{Cite pmid|32600316}}</ref> The cholinergic anti-inflammatory pathway alleviates acute lung injury #MMPMID32600316 Andersson U Mol Med 2020[Jun]; 26 (1): 64 PMID32600316show ga The ubiquiotous nuclear protein HMGB1 is extracellularly released by dying cells or activated innate immunity cells to promote inflammation. Extracellular HMGB1 plays a prominent role in the pathogenesis of acute lung injury of infectious as well as sterile origin including hyperoxia. Excessive amounts of systemic HMGB1 and HMGB1-partner molecule complexes can be retained in the pulmonary circulation indicated by a substantial reduction of HMGB1 plasma levels in arterial versus venous blood. The cholinergic antiinflammatory mechanism ameliorates pulmonary inflammation by inhibiting HMGB1 release and HMGB1 receptor expression. This comprehension was recently reinforced by results reported in Molecular Medicine by Sitapara and coworkers demonstrating that administration of an alpha7 nicotinic acetylcholine receptor agonist attenuated hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation. Activating the cholinergic antiinflammatory path might be considered to alleviate severe COVID-19 with or without concurrent oxygen-induced lung injury. |Acute Lung Injury/immunology/pathology/*prevention & control[MESH] |Animals[MESH] |Betacoronavirus/immunology[MESH] |COVID-19[MESH] |Coronavirus Infections/immunology/pathology/*prevention & control/virology[MESH] |HMGB1 Protein/*antagonists & inhibitors[MESH] |Humans[MESH] |Neuroimmunomodulation/*drug effects[MESH] |Nicotinic Agonists/*therapeutic use[MESH] |Pandemics/*prevention & control[MESH] |Pneumonia, Viral/immunology/pathology/*prevention & control/virology[MESH]The cholinergic anti-inflammatory pathway alleviates acute lung injury(epmc).pdf DeepDyve Pubget Overpricing